http://rdf.ncbi.nlm.nih.gov/pubchem/reference/29034957

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, Non-U.S. Gov't
endingPage 1917
issn 1097-0215
0020-7136
issueIdentifier 8
pageRange 1907-1917
publicationName International Journal of Cancer
startingPage 1907
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_7005285e11494c7ba18bf925b897c40b
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_f3986cbe073f43904dc30ba36bbefb75
bibliographicCitation Baum C, Weiss C, Gebhardt C, Utikal J, Marx A, Koenen W, Géraud C. Sentinel node metastasis mitotic rate (SNMMR) as a prognostic indicator of rapidly progressing disease in patients with sentinel node‐positive melanomas. Intl Journal of Cancer. 2017 Feb 23;140(8):1907–17. doi: 10.1002/ijc.30563.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7183da810f4b5c3f88813ddae3636ba4
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-7090-9584
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8bdb3c7e05a3ac1a2346de50e53b4514
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_94223f636f9c93e2329981d2267d54d7
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d584bbac2611f5d35840ec117468272c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6a749813324ed453a6c22cc8fbaefe66
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e8a4a94e85ff1c0a92af79f9023e4c97
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4f9ffeb644f5fc8427aa4051b7e843ed
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-9432-6869
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-5316-0241
date 2017-02-23^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.1002/ijc.30563
https://pubmed.ncbi.nlm.nih.gov/27935036
isPartOf https://portal.issn.org/resource/ISSN/0020-7136
https://portal.issn.org/resource/ISSN/1097-0215
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/4284
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Sentinel node metastasis mitotic rate (SNMMR) as a prognostic indicator of rapidly progressing disease in patients with sentinel node‐positive melanomas
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D008545Q000175
http://id.nlm.nih.gov/mesh/D008938Q000235
http://id.nlm.nih.gov/mesh/D000071036Q000473
http://id.nlm.nih.gov/mesh/D011379
hasSubjectTerm http://id.nlm.nih.gov/mesh/D008545Q000235
http://id.nlm.nih.gov/mesh/D008207Q000235
http://id.nlm.nih.gov/mesh/D012189
http://id.nlm.nih.gov/mesh/D008875
http://id.nlm.nih.gov/mesh/D008207Q000175
http://id.nlm.nih.gov/mesh/D008545Q000473
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D000096142
http://id.nlm.nih.gov/mesh/D018572
http://id.nlm.nih.gov/mesh/D000328
http://id.nlm.nih.gov/mesh/D008197
http://id.nlm.nih.gov/mesh/D021701
http://id.nlm.nih.gov/mesh/D012878
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D000368
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9245
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_aa29d6984108c685bd651011d6733c00
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8448

Showing number of triples: 1 to 56 of 56.